Diagnosis of AIDS-related focal brain lesions: A decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF

Neurology

Volumn 48, Issue 3, 1997, Pages 687-694

  Antinori, Andrea ^a   Ammassari, A ^a   De Luca, A ^a   Cingolani, A ^a   Murri, R ^a   Scoppettuolo, G ^a   Fortini, M ^c   Tartaglione, T ^a   Larocca, L M ^a   Zannoni, G ^a   Cattani, P ^a   Grillo, R ^a   Roselli, R ^b   Iacoangeli, M ^b   Scerrati, M ^b   Ortona, L ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c ITALIAN NATIONAL INSTITUTE OF STATISTICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DAPSONE;

ADULT; AIDS RELATED COMPLEX; ARTICLE; BRAIN BIOPSY; BRAIN INJURY; BRAIN LYMPHOMA; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; JC VIRUS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0030945490     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.3.687     Document Type: Article

References (43)

1. Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 1983;14:403-418.
2. Luft BJ, Hafner R, Korzun AH, et al. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. N Engl J Med 1993;329:995-1000.
3. Navia BA, Petito CK, Gold JWM, Cho ES, Jordan BD, Price RW. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathologica) findings in 27 patients. Ann Neurol 1986;19:224-238.
4. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992;327:1643-1648.
5. Ammassari A, Murri R, Cingolani A, De Luca A, Antinori A. AIDS-associated cerebral toxoplasmosis: an update on diagnosis and treatment. Curr Top Microbiol Immunol 1996;219: 201-214.
6. Oksenhendler E, Charreau I, Tournerie C, Azihary M, Carbon C, Aboulker JP. Toxoplasma gondii infection in advanced HIV infection. AIDS 1994;8:483-487.
7. Girard PM, Landman R, Gaudebout C, et al. Dapsonepyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 1993;328: 1514-1520.
8. Antinori A, Murri R, Ammassari A, et al. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. AIDS 1995;9:1343-1350.
9. Bacellar H, Munoz A, Miller EN, et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: multicenter AIDS cohort study, 1985-1992. Neurology 1994;44:1892-1900.
10. Pluda JM, Yarchoan R, Jaffe ES, et al. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus infection on long-term antiretroviral therapy. Ann Intern Med 1990;113:276-282.
11. Berger JR, Kaszovitz B, Post MJD, Dickinson G. Progressive multifocal leucoencephalopathy associated with human immunodeficiency virus infection. Ann Intern Med 1987;107:78-87.
12. Cohn JA, McMeeking A, Cohen W, Jacobs J, Holzman RS. Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Am J Med 1989;86:521-527.
13. Haverkos HW for the TE Study Group. Assessment of therapy for Toxoplasma encephalitis. Am J Med 1987;82:907-914.
14. Cimino C, Lipton RB, Williams A, Feraru E, Harris C, Hirschfeld A. The evaluation of patients with human immunodeficiency virus-related disorders and brain mass lesions. Arch Intern Med 1991;151:1381-1384.
15. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41(RR 17):1-19.
16. Cinque P, Brytting M, Vago L, et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993; 342:398-401.
17. De Luca A, Antinori A, Cingolani A, et al. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 1995;90:844-849.
18. De Luca A, Cingolani A, Linzalone A, et al. Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leucoencephalopathy. J Clin Microbiol 1996;34:1343-1346.
19. Dupon M, Cazenave J, Pellegrin JL, et al. Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients. J Clin Microbiol 1995;33:2421-2426.
20. Cingolani A, De Luca A, Ammassari A, et al. PCR detection of Toxoplasma gondii-DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions. J Med Microbiol 1996;45: 472-476.
21. Iacoangeli M, Roselli R, Antinori A, et al. Experience with brain biopsy in acquired immune deficiency syndrome-related focal lesions of the central nervous system. Br J Surg 1994;81: 1508-1511.
22. Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Scientific Publications, 1990.
23. Mood AM, Graybill FA, Boes PC. Introduction to the theory of statistics. New York: McGraw Hill, 1974.
24. Cirillo SF, Rosenblum ML. Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J Neurosurg 1991;73:720-724.
25. Mathews C, Barba D, Fullerton SC, Early biopsy versus empiric treatment with delayed biopsy of non-responders in suspected HIV-associated cerebral toxoplasmosis: a decision analysis. AIDS 1995;9:1243-1250.
26. Baumgartner JE, Rachlin JR, Beckstead JH, et al. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990;73:206-211.
27. Levy RM, Russell E, Yungbluth M, Hidvegi DF, Brody BA, Dal Canto MC. The efficacy of image-guided stereotactic brain biopsy in neurologically symptomatic acquired immunodeficiency syndrome patients. Neurosurgery 1992;30:186-190.
28. Chappell ET, Guthrie BL, Orenstein J. The role of stereotactic biopsy in the management of HIV-related focal brain lesions. Neurosurgery 1992;30:825-829.
29. Luzzati R, Ferrari S, Nicolato A, et al. Stereotactic brain biopsy in human immunodeficiency virus-infected patients. Arch Intern Med 1996;5:565-568.
30. Galleto G, Levine A. AIDS-associated primary central nervous system lymphoma. JAMA 1993;269:92-93.
31. Editorial. Brain biopsy for intracranial mass lesions in AIDS. Lancet 1992;340:1135.
32. Formenti SC, Gill PS, Lean E, et al. Primary central nervous system lymphoma in AIDS. Cancer 1989;63:1101-1107.
33. Forsyth PA, Yahalom J, De Angelis LM. Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology 1994;44:1473-1479.
34. Chamberlain MC. Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma. Cancer 1994;73:1728-1730.
35. Ling SM, Roach M III, Larson DA, Wara WM. Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Cancer 1994;73: 2570-2582.
36. Goldstein JD, Dickson DW, Moser FG, et al. Primary central nervous system lymphoma in acquired immune deficiency syndrome. Cancer 1991;67:2756-2765.
37. Antinori A, Ammassari A, Murri R, et al. Primary central nervous system lymphoma and brain biopsy in AIDS. Lancet 1993;341:1411-1412.
38. Donahue BR, Sullivan JW, Cooper JS. Additional experience with empiric radiotherapy for presumed human immunodeficiency virus-associated primary central nervous system lymphoma. Cancer 1995;76:328-332.
39. Corn BW, Trock BJ, Curran WJ Jr. Management of primary central nervous system lymphoma for the patient with acquired immunodeficiency syndrome. Cancer 1995;76:163-166.
40. 201TE single-photon emission computed tomography. AJR Am J Roentgenol 1994;163:417-421.
41. Hoffman JM, Waskin HA, Schifter T, et al. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 1993;34: 567-575.
42. Antinori A, De Luca A, Ammassari A, et al. Failure of cytarabine and increased JC virus-DNA burden in the cerebrospinal fluid of patients with AIDS-related progressive multifocal leucoencephalopathy. AIDS 1994;8:1022-1024.
43. Vach W. Logistic regression with missing values in the covariates. New York: Springer-Verlag, 1994.